Preventive Care
News from the FDA/CDC
Just over half of pregnant women got flu vaccine in 2016-2017
Coverage rates were much higher when providers recommended vaccination.
From the Journals
VIDEO: Alcohol showed no cardiovascular benefits in nonalcoholic fatty liver disease
Long-term prospective studies are needed to better understand how types and doses of alcohol affect cardiovascular endpoints in patients with...
Conference Coverage
Insist on flu vaccination for all, say experts
Flu vaccines are important for people of all ages after 6 months.
Conference Coverage
Clinicians: Be clear about flu vaccine’s value
A strong recommendation from a clinician can encourage individuals to get vaccinated for influenza and to vaccinate their children.
Conference Coverage
How to lower blood pressure in real-world primary care clinics
A commonsense quality improvement program increased the rate of blood pressure control at 16 South Carolina primary care clinics.
News
FDA offers 2 tools to snuff out risk for e-cigarette fires and explosions
Amid concerns regarding e-cigarette safety, FDA steps in to help consumers stay safe and report alarming incidents.
Conference Coverage
Preferred osteoporosis treatment order with teriparatide, denosumab reaffirmed
DENVER – The findings reinforce the use of an anabolic agent followed by an antiresorptive agent, rather than the other way around.
Conference Coverage
VIDEO: Educational intervention boosts A fib anticoagulation
BARCELONA – Patient education and feedback increased anticoagulation and cut strokes.
Feature
HPV vaccine pioneers win 2017 Lasker-DeBakey Clinical Medical Research Award
Dr. Lowy and Dr. Schiller developed the technology needed to created the HPV vaccine.
Latest News
Suicide attempts on the rise among young U.S. adults
Authors call for training programs to help frontline clinicians manage self-harm among patients with borderline personality disorder.
From the Journals
New data prompt update to ACC guidance on nonstatin LDL lowering
The ACC has updated its advice regarding the use of nonstatin therapies following clinical trial results of PCSK9 inhibitors and ezetimibe.